Eagle Pharma To Pay $9.5M To End Channel Stuffing Claims
Eagle Pharmaceuticals Inc. and its former executives have agreed to pay $9.5 million to settle investor claims that they carried out a fraudulent "channel stuffing" scheme to inflate the revenue of...To view the full article, register now.
Already a subscriber? Click here to view full article